Market Overview

Why Axonics Modulation's Stock Is Trading Higher Today


Axonics Modulation Technologies Inc (NASDAQ: AXNX) shares are trading higher on Wednesday.

The company reported FDA approval of its wireless patient remote control with MartMRI technology.

Axonics Modulation Technologies Inc is a U.S. based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.

The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence

Axonics Modulation shares were trading up 3.19% at $38.80 on Wednesday. The stock has a 52-week range between $43.37 and $15.25.


Related Articles (AXNX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews FDA